David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
CALL
Marathon Petroleum
MPC
$99.7B
| $12.7M | 0.02% |
212,700
+78,400
| +58% | +$4.93M |
|
927
CenterPoint Energy
CNP
$25.6B
| $12.7M | 0.02% |
414,324
-502,064
| -55% | -$15.2M |
|
|
NAV
928
DELISTED
Navistar International
NAV
| $12.7M | 0.02% |
393,444
+69,439
| +21% | +$2.31M |
|
929
Alkermes
ALKS
$8.26B
| $12.7M | 0.02% |
347,758
+232,885
| +203% | +$7.69M |
|
930
Oceaneering
OII
$4.97B
| $12.7M | 0.02% |
803,824
+117,136
| +17% | +$1.81M |
|
931
Medpace
MEDP
$17.1B
| $12.6M | 0.02% |
214,172
-85,293
| -28% | -$5.09M |
|
932
Open Text
OTEX
$5.9B
| $12.6M | 0.02% |
327,259
+18,526
| +6% | +$677K |
|
|
TIF
933
PUT
DELISTED
Tiffany & Co.
TIF
| $12.6M | 0.02% |
119,100
+99,100
| +496% | +$9.1M |
|
|
FIT
934
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $12.5M | 0.02% |
+2,118,586
| New | +$12.9M |
|
935
DaVita
DVA
$11.3B
| $12.5M | 0.02% |
230,974
-115,117
| -33% | -$6.37M |
|
|
ECHO
936
EchoStar
ECHO
$25.1B
| $12.5M | 0.02% |
424,394
+105,858
| +33% | +$3.34M |
|
937
Shopify
SHOP
$198B
| $12.5M | 0.02% |
605,550
-1,277,800
| -68% | -$22.6M |
|
938
Rockwell Automation
ROK
$47.7B
| $12.5M | 0.02% |
71,122
-42,634
| -37% | -$7.25M |
|
|
ABMD
939
CALL
DELISTED
Abiomed Inc
ABMD
| $12.5M | 0.02% |
43,600
-18,200
| -29% | -$6.05M |
|
940
SEI Investments
SEIC
$13.3B
| $12.4M | 0.02% |
238,224
+60,184
| +34% | +$3.01M |
|
941
Standard BioTools
LAB
$255M
| $12.4M | 0.02% |
933,689
+712,728
| +323% | +$7.51M |
|
942
Hancock Whitney
HWC
$5.99B
| $12.4M | 0.02% |
306,950
-77,539
| -20% | -$3.18M |
|
|
WCG
943
DELISTED
Wellcare Health Plans, Inc.
WCG
| $12.4M | 0.02% |
45,882
-130,660
| -74% | -$33.8M |
|
944
CALL
Ford
F
$55.6B
| $12.4M | 0.02% |
1,409,300
+114,300
| +9% | +$982K |
|
|
SJR
945
DELISTED
Shaw Communications Inc.
SJR
| $12.4M | 0.02% |
593,039
-7,546
| -1% | -$153K |
|
946
JetBlue
JBLU
$1.92B
| $12.3M | 0.02% |
754,106
+265,314
| +54% | +$4.54M |
|
947
Churchill Downs
CHDN
$6.18B
| $12.3M | 0.02% |
272,142
+64,368
| +31% | +$2.87M |
|
948
Manhattan Associates
MANH
$12.4B
| $12.3M | 0.02% |
222,575
-1,496
| -0.7% | -$76.5K |
|
949
CALL
Deckers Outdoor
DECK
$12.1B
| $12.3M | 0.02% |
500,400
-137,400
| -22% | -$3.12M |
|
950
Hilton Grand Vacations
HGV
$3.49B
| $12.2M | 0.02% |
396,911
-651,355
| -62% | -$20M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.